EWA
GSK icon

Evolution Wealth Advisors’s GSK GSK Stock Holding History

Evolution Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-208
Closed -$10.7K – 548
2020
Q1 		$10K Buy
208
+33
+19% +$1.76K ﹤0.01% 209
2019
Q4 		$10K Sell
175
-17
-9% -$946 ﹤0.01% 303
2019
Q3 		$10K Buy
+192
New +$9.88K ﹤0.01% 171

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Evolution Wealth Advisors's GSK Position: Q2 2020 in Review

Evolution Wealth Advisors sold out of GSK (GSK) in Q2 2020, closing a stake of 208 shares — an estimated $10.7K sold.

Evolution Wealth Advisors first reported a position in GSK in Q3 2019 and held it in 3 quarters. The position peaked at $10K in Q1 2020. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Evolution Wealth Advisors reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Evolution Wealth Advisors sold 208 GSK shares in Q2 2020, an estimated $10.7K.
  • Evolution Wealth Advisors first reported a position in GSK in Q3 2019 and held it in 3 quarters.
  • Evolution Wealth Advisors's GSK position peaked at $10K in Q1 2020.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Evolution Wealth Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.